Weiping Zeng
4PUBLICATIONS
59CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Oct 29, 2025
Targeted Delivery of a Potent STING Agonist Payload via an Antibody-Drug Conjugate Drives Robust Antitumor Activity in Preclinical Models.David R Gruber, Elizabeth J Cummins, Weiping Zeng
|Apr 28, 2025
PF-08046032: A Novel, Investigational CD25-Directed Antibody-Drug Conjugate Optimized for Selective Depletion of Regulatory T Cells in Advanced Malignant Tumors.Sherif Abdelhamed, Xinqun Zhang, Weiping Zeng
|Oct 28, 2024
Preclinical Development of SGN-CD47M: Protease-Activated Antibody Technology Enables Selective Tumor Targeting of the Innate Immune Checkpoint Receptor CD47.Matthew R Levengood, Christopher M Carosino, Xinqun Zhang
|Sep 29, 2023
Brentuximab Vedotin-Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity.Ryan A Heiser, Anthony T Cao, Weiping Zeng
Pageof 1
Frequent Collaborators
4 joint publications
Shyra J Gardai
2 joint publications
Ryan A Heiser
2 joint publications
Bryan Grogan
2 joint publications
Michelle Ulrich
2 joint publications
Peter D Senter
2 joint publications
Devra J Olson
2 joint publications
Melissa Mc Dominguez
2 joint publications
Xinqun Zhang
2 joint publications
Christopher M Carosino
2 joint publications
Matthew R Levengood
